US-China trade war leaves gap for Indian pharma to grow
A data analyst has reported that the current US-China trade war will give India chance to increase their pharmaceutical presence.
List view / Grid view
A data analyst has reported that the current US-China trade war will give India chance to increase their pharmaceutical presence.
Catalyst Pharmaceuticals Inc has sued the FDA to challenge the recent approval of a lower-cost rival drug.
A new report predicts that the packaging and labelling industry for pharmaceutical products will increase by 5.3 percent.
A study has shown that the majority of dermatology advisors to the FDA took payments subsequent to drug approvals.
Luxembourg and the Netherlands have been included in the mutual recognition agreement between the EU and the FDA in the US.
A total of 48 US states are now suing Purdue Pharma, claiming they falsely marketed their opioid drug.
The global contraceptive pill market is expected to increase to US$8.8 billion by 2024, report finds.
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
The global biobetters market is set to increase due to demand for higher efficacy and safer drugs.
A research team from Scripps Research Translational Institute has published revealing figures in relation to drug prices in the US.
New briefing documents provide policy recommendations to help the EU tackle high medicines prices brought about by market monopolies.
The EMA has accepted Prestige BioPharma’s marketing application for its trastuzumab biosimilar.
GlaxoSmithKline (GSK) has been given Chinese approval for its shingles vaccine.
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.